Alliqua BioMedical is a regenerative technologies company which commercializes regenerative medical products that assist the body in the repair or replacement of soft tissue. It markets MIST Ultrasound Healing Therapy, a painless, noncontact, low-frequency ultrasound to promote healing, Biovance Amniotic Membrane Allograft and Interfyl Human Connective Tissue Matrix that are human biologic regenerative technologies, and TheraBond 3D Antimicrobial Barrier Systems that promotes an optimal wound healing by creating an antimicrobial barrier that helps protect against infection. The Company also provides contract manufacturing services, including the development, manufacture, and market of high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics.

Employee Rating

2.2More
TypePublic
HQYardley, US
Founded1997
Size (employees)81 (est)
Websitealliqua.com
Alliqua was founded in 1997 and is headquartered in Yardley, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Alliqua

David Johnson

David Johnson

CEO, and Member of the Board of Directors
Brad C. Barton

Brad C. Barton

COO
Brian Posner

Brian Posner

CFO
Phillip Forman

Phillip Forman

Executive VP Clinical Affairs
Nino Pionati

Nino Pionati

Chief Strategy and Marketing Officer
Gregory Robb

Gregory Robb

VP Operations
Show more

Alliqua Office Locations

Alliqua has an office in Yardley
Yardley, (HQ)
1010 Stony Hill Road, Suite 200
Show all (1)
Report incorrect company information

Alliqua Financials and Metrics

Alliqua Revenue

Alliqua's revenue was reported to be $18.24 m in FY, 2016 which is a 21.3% increase from the previous period.
USD

Net income (Q3, 2018)

(754.0k)

EBIT (Q3, 2018)

(970.0k)

Market capitalization (4-Dec-2018)

11.8m

Closing stock price (4-Dec-2018)

2.4

Cash (30-Sep-2018)

11.1m
Alliqua's current market capitalization is $11.8 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

1.8m4.8m15.0m18.2m

Revenue growth, %

166%214%21%

Cost of goods sold

2.1m3.3m6.0m6.7m6.8m

Gross profit

(299.3k)1.5m9.0m11.6m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Revenue

438.0k

Cost of goods sold

586.7k631.7k836.7k915.8k1.2m1.4m1.7m1.8m1.6m1.8m1.7m1.9m1.5m1.7m593.0k361.0k

Gross profit

(148.7k)

Gross profit Margin, %

(34%)
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

12.1m16.8m26.1m5.6m2.2m

Accounts Receivable

156.8k968.6k2.5m2.8m3.2m

Inventories

501.5k477.8k3.1m2.7m1.6m

Current Assets

12.8m19.6m32.7m11.8m7.5m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Cash

420.2k9.6m23.8m19.9m10.9m35.8m30.7m17.0m12.6m10.7m2.4m2.3m2.1m1.5m11.0m11.1m

Accounts Receivable

144.5k164.1k474.4k715.6k1.4m2.3m2.4m2.5m2.5m2.7m2.9m3.6m2.9m4.0m442.0k172.0k

Inventories

305.7k501.1k940.7k1.1m1.6m2.9m3.5m3.5m3.1m3.2m2.6m2.8m2.0m1.7m139.0k183.0k

Current Assets

955.4k10.5m25.3m22.0m14.8m41.7m37.5m24.1m23.5m17.6m8.3m8.9m7.8m7.6m13.0m12.2m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(22.0m)(25.4m)(26.0m)(28.2m)(25.7m)

Depreciation and Amortization

674.2k2.9m4.2m5.4m

Inventories

(241.1k)477.8k(1.4m)(113.0k)792.0k

Accounts Payable

174.0k1.8m571.6k(26.0k)(1.0m)
USDY, 2018

Financial Leverage

1.3 x
Show all financial metrics
Report incorrect company information

Alliqua Online and Social Media Presence

Embed Graph
Report incorrect company information

Alliqua News and Updates

Thinking about buying stock in Apple, Alliqua BioMedical, Inc., Advanced Micro Devices, Dollar Tree, Inc. or New Age Beverages Corp.?

CHICAGO, Nov. 29, 2018 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AAPL, ALQA, AMD, DLTR, and NBEV. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....

Alliqua BioMedical Inc. and Adynxx, Inc. Announce Merger Agreement to Create NASDAQ-listed Clinical-Stage Pharmaceutical Company with a Focus on Pain and Inflammation

LANGHORNE, Pa. and SAN FRANCISCO, Oct. 12, 2018 (GLOBE NEWSWIRE) -- Alliqua BioMedical, Inc. (Nasdaq:ALQA) and Adynxx, Inc., a privately held biopharmaceutical company, today announced that they have entered into a definitive merger agreement under which the stockholders of Adynxx would become the…
Report incorrect company information

Alliqua Company Life and Culture

Report incorrect company information

Alliqua Frequently Asked Questions

  • When was Alliqua founded?

    Alliqua was founded in 1997.

  • Who are Alliqua key executives?

    Alliqua's key executives are David Johnson, Brad C. Barton and Brian Posner.

  • How many employees does Alliqua have?

    Alliqua has 81 employees.

  • Who are Alliqua competitors?

    Competitors of Alliqua include ImmunoCellular Therapeutics, Gamma Medica and Boule Diagnostics.

  • Where is Alliqua headquarters?

    Alliqua headquarters is located at 1010 Stony Hill Road, Suite 200 , Yardley.

  • Where are Alliqua offices?

    Alliqua has an office in Yardley.

  • How many offices does Alliqua have?

    Alliqua has 1 office.